- Reaction score
- 686
If i read this correct SM04554 is in phase 2 on the clinical trial side.
source: https://clinicaltrials.gov/ct2/show/NCT03742518?term=samumed&rank=6
But on the webside of samumed the pipeline chart shows phase 3 for Androgenetic Alopecia.
But than again the press release says phase 2/3 trial.
That means either the phase 2 is just an opertunity and if the results are good they take it as phase 3. Which would mean mid 2020 result are available so best case scenario mid 2021 the treatment is available. If they really do a phase 2 trial with the active ingredient we should wait till 2024 at least to see the product.
Maybe that is the reason why not so many people are talking about that.
source: https://clinicaltrials.gov/ct2/show/NCT03742518?term=samumed&rank=6
But on the webside of samumed the pipeline chart shows phase 3 for Androgenetic Alopecia.
But than again the press release says phase 2/3 trial.
That means either the phase 2 is just an opertunity and if the results are good they take it as phase 3. Which would mean mid 2020 result are available so best case scenario mid 2021 the treatment is available. If they really do a phase 2 trial with the active ingredient we should wait till 2024 at least to see the product.
Maybe that is the reason why not so many people are talking about that.